SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-051420
Filing Date
2020-11-05
Accepted
2020-11-05 16:49:49
Documents
69
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q myok-10q_20200930.htm   iXBRL 10-Q 2684276
2 EX-10.1 myok-ex101_331.htm EX-10.1 50274
3 EX-31.1 myok-ex311_7.htm EX-31.1 15759
4 EX-31.2 myok-ex312_9.htm EX-31.2 15843
5 EX-32.1 myok-ex321_6.htm EX-32.1 8711
  Complete submission text file 0001564590-20-051420.txt   8467316

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA myok-20200930.xsd EX-101.SCH 50338
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE myok-20200930_cal.xml EX-101.CAL 55696
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE myok-20200930_def.xml EX-101.DEF 138773
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE myok-20200930_lab.xml EX-101.LAB 381744
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myok-20200930_pre.xml EX-101.PRE 284117
11 EXTRACTED XBRL INSTANCE DOCUMENT myok-10q_20200930_htm.xml XML 1580347
Mailing Address 1000 SIERRA POINT PARKWAY BRISBANE CA 94005
Business Address 1000 SIERRA POINT PARKWAY BRISBANE CA 94005 650-741-0900
MyoKardia, Inc. (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37609 | Film No.: 201291267
SIC: 2834 Pharmaceutical Preparations